Updates on the Evolving Role of Multidisciplinary Care Teams for the Management of Patients with Duchenne Muscular Dystrophy
Released On
May 6, 2024
Expires On
May 6, 2025
Media Type
Internet
Completion Time
75 minutes
Specialty
Genetics, Neurology, Pediatrics, Pharmacy
Topic(s)
Duchenne Muscular Dystrophy, DMD
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Pfizer Inc.
Credit Available
- Physicians — maximum of 1.25 AMA PRA Category 1 Credits™
- Nurses — maximum of 1.25 ANCC contact hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
These educational activities are designed for neurologists, pediatric neurologists, global pharmacists, specialty nurses, genetic counselors, medical geneticists, and other physicians involved in multidisciplinary care teams for DMD management.
Program Overview
This enduring activity focuses on improving the care of patients with Duchenne muscular dystrophy (DMD) with regard to effective diagnosis, referral, and treatment. Additionally, the faculty will aim to present standardized strategies for effective care coordination between DMD multidisciplinary care team members.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Develop standardized strategies for effective care coordination between DMD multidisciplinary care team members
- Improve care for patients with DMD facing barriers to effective diagnosis, referral, and treatment cancers to maximize patient outcomes through proper sequencing of therapy
Faculty
Emma Ciafaloni, MD, FAAN
Program Co-Chair
Robert C. and Rosalyne H. Griggs Professor in Experimental Therapeutics of Neurologic Disease
Professor of Neurology, Pediatrics, and Obstetrics & Gynecology
Associate Chair of Research-Neurology
Director Pediatric Neuromuscular Medicine
University of Rochester
Rochester, NY
Oscar Henry Mayer, MD
Program Co-Chair
Division of Pulmonology
Medical Director, Pulmonary Function Testing Laboratory The Children's Hospital of Philadelphia
Professor of Clinical Pediatrics
The Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA
Joan Mountain, RN, BS, AMB-BC
Panelist
Neuromuscular Clinical Coordinator
University of Rochester
Rochester, NY
Charlie, with Cheryl and Charles Prior
Panelist
Manlius, NY
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing Continuing Education Credit Designation
Med Learning Group designates this activity for a maximum of 1.25 ANCC contact hours.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Responsibility
- Emma Ciafaloni, MD
- Discloses receiving consulting fees and reports contracted research from Sarepta Therapeutics
- Oscar Henry Mayer, MD
- Has nothing to disclose.
- Joan Mountain, RN
- Has nothing to disclose.
- Charlie, with Cheryl and Charles Prior
- Has nothing to disclose.
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer-reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Chris Drury, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
Mike Milano, MD, has received royalties from Wolters Kluwer (Up ToDate author royalties).
Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact: Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
